Danvers-based Aiomed Inc., a provider of heart support technologies, said that physicians have implanted more than 15,000 of its Impella pumps in US patients. But shares fell on first-quarter 2014 revenue of $42.7 million, up 10 percent over the same period last year but short of analysts’ estimates of $42.93 million. The per share loss was 4 cents, compared to 8 cents in the prior period. First-quarter worldwide Impella revenue totaled $38.7 million, up 12 percent. Full story for BostonGlobe.com subscribers.
This is a summary. To read the whole story subscribe to BostonGlobe.com
© Copyright 2013 Globe Newspaper Company.
Get the full story with unlimited access to BostonGlobe.com. Just 99¢ for 4 weeks.